Form 4 for NVST Envista Holdings Corp

Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-25 · accession 0001757073-24-000025 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-02-27	2024-02-25	NVST	Befidi Robert	Pres, Diagnostics	A - Grant	$0.00	+9,385	43.2K	+28%	$0
DM	2024-02-27	2024-02-25	NVST	Befidi Robert	Pres, Diagnostics	A - Grant	$0.00	+39.2K	17.3K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-25	A	A	9,385	$0.00	43,245	D	—	—	(F1) Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
2	Derivative	Employee Stock Option (Right to Buy)	2024-02-25	A	A	21,910	$0.00	21,910	D	$22.65 · — to 2034-02-25	21,910 Common Stock	(F3) This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
3	Derivative	Performance Share Unit	2024-02-25	A	A	17,260	$0.00	17,260	D	— · — to —	17,260 Common Stock	(F2) Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.